2007
DOI: 10.1080/09513590701321565
|View full text |Cite
|
Sign up to set email alerts
|

Aromatase expression in the eutopic endometrium of myomatous uteri: The influence of the menstrual cycle and oral contraceptive use

Abstract: Aromatase expression in the endometrium was affected by the location of the myoma, the presence of symptoms, and the phase of the menstrual cycle. Oral contraceptives, on the other hand, inhibited aromatase expression in the eutopic endometrium of patients with submucous/intramural myomas.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 22 publications
0
11
0
Order By: Relevance
“…The hormonal and inflammatory factors that regulate aromatase expression in the endometrium are therefore important for the survival of endometrial cells in the peritoneal cavity, their subsequent implantation and the formation of endometriotic lesions [5]. In patients with myomas, aromatase expression in the endometrium is lower during the luteal phase, thus suggesting an inhibitory effect of progesterone [6]. Similarly in peripheral macrophages, aromatase expression was also found to diminish significantly during the luteal phase compared with the other phases of the menstrual cycle [7].…”
Section: Introductionmentioning
confidence: 99%
“…The hormonal and inflammatory factors that regulate aromatase expression in the endometrium are therefore important for the survival of endometrial cells in the peritoneal cavity, their subsequent implantation and the formation of endometriotic lesions [5]. In patients with myomas, aromatase expression in the endometrium is lower during the luteal phase, thus suggesting an inhibitory effect of progesterone [6]. Similarly in peripheral macrophages, aromatase expression was also found to diminish significantly during the luteal phase compared with the other phases of the menstrual cycle [7].…”
Section: Introductionmentioning
confidence: 99%
“…COX-2, which converts arachidonic acid into prostaglandin H 2 (precursor of all prostaglandins [PGs] and thromboxanes), represents a mitogen-induced form of cyclooxygenase, manifesting expression in response to various inflammatory stimuli including IL-1b and TNF-a. In myometrium and endometrium estrogens stimulate COX-2 to synthesize PGE 2 [13]. The PGE 2 is associated with proinflammatory mechanisms and could enhance the function of NFkB, whereas the PGA 1, PGA 2 and PGJ 2 are associated with suppression of inflammation and are able to inhibit NF-kB activation [14][15][16].…”
Section: Introductionmentioning
confidence: 99%
“…Estrogens stimulate COX-2 to synthesize PGE2 in myometrium. 37 PGE2 is known to enhance activation of NF-kB and the production of proinflammatory cytokines. On the other hand, PGA1, PGA2, and PGJ2 are associated with the suppression of inflammation and are able to inhibit NF-kB activation.…”
Section: Estrogen and Myometrium Immunitymentioning
confidence: 99%